...
机译:SOX2介导的CD24的上调促进了黑色素瘤的靶向治疗的自适应抗性
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg and Department of Dermatology;
SOX2; CD24; BRAF inhibitor; adaptive resistance;
机译:SOX2介导的CD24的上调促进了黑色素瘤的靶向治疗的自适应抗性
机译:蒂姆-3上调对抗PD1治疗的自适应抗性由头部和颈部癌症中的PI3K-AKT途径介导
机译:通过MiR-372-3P诱导ATG5 / ATG12介导的自噬促进KCNQ1OT1的升高促进对肺腺癌的立体定向体放射疗法
机译:癌细胞中联合光动力疗法(cPDT)后反应增强的机制涉及cop4roporphyrinphyrinogen氧化酶(CPO)基因的C / EBP介导的转录上调
机译:果糖促进黑色素瘤肿瘤的细胞或抗免疫疗法
机译:STAT3依赖性SOX2和CD24表达在黑色素瘤细胞针对靶向疗法的适应性耐药中的作用
机译:SOX2介导的CD24的上调促进了黑色素瘤的靶向治疗的自适应抗性